Related references
Note: Only part of the references are listed.9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2021
DIABETES CARE (2021)
8. Obesity Management for the Treatment of Type 2 Diabetes: Standards of Medical Care in Diabetes-2021
DIABETES CARE (2021)
Contemporary Updates on the Physiology of Glucagon like Peptide-1 and Its Agonist to Treat Type 2 Diabetes Mellitus
Anju Das et al.
INTERNATIONAL JOURNAL OF PEPTIDE RESEARCH AND THERAPEUTICS (2020)
RGS6 Mediates Effects of Voluntary Running on Adult Hippocampal Neurogenesis (vol 32, pg 107997-1, 2020)
Yu Gao et al.
CELL REPORTS (2020)
Adipocyte-specific deletion of IL-6 does not attenuate obesity-induced weight gain or glucose intolerance in mice
Martin Whitham et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2019)
Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition
Pouya Saeedi et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2019)
Treatment of type 2 diabetes with the designer cytokine IC7Fc
Maria Findeisen et al.
NATURE (2019)
Metformin: Mechanisms in Human Obesity and Weight Loss
Armen Yerevanian et al.
CURRENT OBESITY REPORTS (2019)
SGLT-2 inhibitors and the risk of lower-limb amputation: Is this a class effect?
Charles Khouri et al.
DIABETES OBESITY & METABOLISM (2018)
Association Between Use of Sodium-Glucose Cotransporter 2 Inhibitors, Glucagon-like Peptide 1 Agonists, and Dipeptidyl Peptidase 4 Inhibitors With All-Cause Mortality in Patients With Type 2 Diabetes A Systematic Review and Meta-analysis
Sean L. Zheng et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
An update on sodium-glucose co-transporter-2 inhibitors for the treatment of diabetes mellitus
Daniel S. Hsia et al.
CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY (2017)
Therapeutic Targeting of the IL-6 Trans-Signaling/Mechanistic Target of Rapamycin Complex 1 Axis in Pulmonary Emphysema
Saleela M. Ruwanpura et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2016)
Blocking IL-6 trans-Signaling Prevents High-Fat Diet-Induced Adipose Tissue Macrophage Recruitment but Does Not Improve Insulin Resistance
Michael J. Kraakman et al.
CELL METABOLISM (2015)
The Hippo pathway effector YAP controls mouse hepatic stellate cell activation
Inge Mannaerts et al.
JOURNAL OF HEPATOLOGY (2015)
Analysis of IL-6/gp130 Family Receptor Expression Reveals That in Contrast to Astroglia, Microglia Lack the Oncostatin M Receptor and Functional Responses to Oncostatin M
Meng-Ping Hsu et al.
GLIA (2015)
Role of interleukins in obesity: implications for metabolic disease
Mark A. Febbraio
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2014)
Transsignaling of Interleukin-6 Crucially Contributes to Atherosclerosis in Mice
Harald Schuett et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)
IL-6/IL-6 receptor system and its role in physiological and pathological conditions
Masahiko Mihara et al.
CLINICAL SCIENCE (2012)
Contraction-induced Interleukin-6 Gene Transcription in Skeletal Muscle Is Regulated by c-Jun Terminal Kinase/Activator Protein-1
Martin Whitham et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
The pro- and anti-inflammatory properties of the cytokine interleukin-6
Juergen Scheller et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2011)
Selective blockade of interleukin-6 trans-signaling improves survival in a murine polymicrobial sepsis model
Tanja Barkhausen et al.
CRITICAL CARE MEDICINE (2011)
Relative Muscle Mass Is Inversely Associated with Insulin Resistance and Prediabetes. Findings from The Third National Health and Nutrition Examination Survey
Preethi Srikanthan et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells
Helga Ellingsgaard et al.
NATURE MEDICINE (2011)
Clodronate Liposomes Improve Metabolic Profile and Reduce Visceral Adipose Macrophage Content in Diet-Induced Obese Mice
Bin Feng et al.
PLOS ONE (2011)
Type 2 diabetes as an inflammatory disease
Marc Y. Donath et al.
NATURE REVIEWS IMMUNOLOGY (2011)
Is Interleukin-6 Receptor Blockade the Holy Grail for Inflammatory Diseases?
M. A. Febbraio et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
Human IL6 enhances leptin action in mice
M. Sadagurski et al.
DIABETOLOGIA (2010)
Interleukin-6-deficient mice develop hepatic inflammation and systemic insulin resistance
V. B. Matthews et al.
DIABETOLOGIA (2010)
Receptor-Fc fusion therapeutics, traps, and MIMETIBODY™ technology
Chichi Huang
CURRENT OPINION IN BIOTECHNOLOGY (2009)
Thiazolidinedione-induced skeletal fragility - mechanisms and implications
Andrew Grey
DIABETES OBESITY & METABOLISM (2009)
Context-dependent IL-6 potentiation of interferon- gamma-induced IL-12 secretion and CD40 expression in murine microglia
Hsiao-Wen Lin et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Fc-based cytokines - Prospects for engineering superior therapeutics
Jalal A. Jazayeri et al.
BIODRUGS (2008)
Ablation of CD11c-Positive Cells Normalizes Insulin Sensitivity in Obese Insulin Resistant Animals
David Patsouris et al.
CELL METABOLISM (2008)
Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial
Josef S. Smolen et al.
LANCET (2008)
Interleukin-6 regulates pancreatic α-cell mass expansion
Helga Ellingsgaard et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Transgenic blockade of interleukin 6 transsignaling abrogates inflammation
Bjorn Rabe et al.
BLOOD (2008)
Gp130 receptor ligands as potential therapeutic targets for obesity
Mark A. Febbraio
JOURNAL OF CLINICAL INVESTIGATION (2007)
DPP-4 inhibitors and their potential role in the management of type 2 diabetes
A. Barnett
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2006)
Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-activated protein kinase
Andrew L. Carey et al.
DIABETES (2006)
Ciliary neurotrophic factor suppresses hypothalamic AMP-kinase signaling in leptin-resistant obese mice
Gregory R. Steinberg et al.
ENDOCRINOLOGY (2006)
gp130 signaling in proopiomelanocortin neurons mediates the acute anorectic response to centrally applied ciliary neurotrophic factor
Ruth Janoschek et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
CNTF reverses obesity-induced insulin resistance by activating skeletal muscle AMPK
Matthew J. Watt et al.
NATURE MEDICINE (2006)
Ciliary neurotrophic factor prevents acute lipid-induced insulin resistance by attenuating ceramide accumulation and phosphorylation of c-Jun N-terminal kinase in peripheral tissues
MJ Watt et al.
ENDOCRINOLOGY (2006)
Neurogenesis in the hypothalamus of adult mice: Potential role in energy balance
MV Kokoeva et al.
SCIENCE (2005)
Interleukin-6 depletion selectively improves hepatic insulin action in obesity
PJ Klover et al.
ENDOCRINOLOGY (2005)
Pathophysiology of type 2 diabetes: Rationale for different oral antidiabetic treatment strategies
F Giorgino et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2005)
Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB
DS Cai et al.
NATURE MEDICINE (2005)
AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus
Y Minokoshi et al.
NATURE (2004)
Soluble interleukin-6 receptor (slL-6R) in cerebrospinal fluid of patients with inflammatory and non inflammatory neurological diseases
M Michalopoulou et al.
IMMUNOLOGY LETTERS (2004)
Central role of suppressors of cytokine signaling proteins in hepatic steatosis, insulin resistance, and the metabolic syndrome in the mouse
K Ueki et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Socs3 deficiency in the brain elevates leptin sensitivity and confers resistance to diet-induced obesity
H Mori et al.
NATURE MEDICINE (2004)
Enhanced leptin sensitivity and attenuation of diet-induced obesity in mice with haploinsufficiency of Socs3
JK Howard et al.
NATURE MEDICINE (2004)
Interleukin-6 and tumor necrosis factor-α are not increased in patients with Type 2 diabetes:: evidence that plasma interleukin-6 is related to fat mass and not insulin responsiveness
AL Carey et al.
DIABETOLOGIA (2004)
Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. Petersen KF, Dufour S, Befroy D, Garcia R, Shulman GI. N Engl J Med 2004; 350: 664-71.
F Razak et al.
VASCULAR MEDICINE (2004)
Acquiring signalling specificity from the cytokine receptor gp130
M Ernst et al.
TRENDS IN GENETICS (2004)
Ciliary neurotrophic factor: a role in obesity?
E Duff et al.
NUTRITION REVIEWS (2003)
Ciliary neurotrophic factor improves diabetic parameters and hepatic steatosis and increases basal metabolic rate in db/db mice
MW Sleeman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Cellular cholesterol depletion triggers shedding of the human interleukin-6 receptor by ADAM10 and ADAM17 (TACE)
V Matthews et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Molecular phylogeny within type I cytokines and their cognate receptors
JL Boulay et al.
IMMUNITY (2003)
PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes
VK Mootha et al.
NATURE GENETICS (2003)
Suppressor of cytokine signaling-3 (SOCS-3), a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes
JJ Senn et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Recombinant variant of ciliary neurotrophic factor for weight loss in obese adults - A randomized, dose-ranging study
MP Ettinger et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
AMPK expression and phosphorylation are increased in rodent muscle after chronic leptin treatment
GR Steinberg et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2003)
Effect of pegylation on pharmaceuticals
JM Harris et al.
NATURE REVIEWS DRUG DISCOVERY (2003)
Obesity is associated with macrophage accumulation in adipose tissue
SP Weisberg et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Chronic exposure to interleukin-6 causes hepatic insulin resistance in mice
PJ Klover et al.
DIABETES (2003)
A central role for JNK in obesity and insulin resistance
J Hirosumi et al.
NATURE (2002)
Leptin increases FA oxidation in lean but not obese human skeletal muscle: evidence of peripheral leptin resistance
GR Steinberg et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2002)
Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase
Y Minokoshi et al.
NATURE (2002)
Interleukin-6-deficient mice develop mature-onset obesity
V Wallenius et al.
NATURE MEDICINE (2002)
Effector function activities of a panel of mutants of a broadly neutralizing antibody against human immunodeficiency virus type 1
M Hezareh et al.
JOURNAL OF VIROLOGY (2001)
Ciliary neurotrophic factor activates leptin-like pathways and reduces body fat, without cachexia or rebound weight gain, even in leptin-resistant obesity
PD Lambert et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
LPS induction of gene expression in human monocytes
M Guha et al.
CELLULAR SIGNALLING (2001)
Identification of the Y985 and Y1077 motifs as SOCS3 recruitment sites in the murine leptin receptor
S Eyckerman et al.
FEBS LETTERS (2000)
Production of interleukin-6 in contracting human skeletal muscles can account for the exercise-induced increase in plasma interleukin-6
A Steensberg et al.
JOURNAL OF PHYSIOLOGY-LONDON (2000)
Effect of prolonged, submaximal exercise and carbohydrate ingestion on monocyte intracellular cytokine production in humans
RL Starkie et al.
JOURNAL OF PHYSIOLOGY-LONDON (2000)
Insulin signaling and insulin sensitivity after exercise in human skeletal muscle
JFP Wojtaszewski et al.
DIABETES (2000)
Share Paper
